Profile banner
Lisa Ward

Lisa Ward

Head of Portfolio Talent and Value Creation at Mercia Ventures

United Kingdom
Joined October 2025

Network

2.3K connections
🤝
External Investors NEDs
💰
Mercia Investment Team
⚙️
Mercia Operations Finance
💡
VC Platform Talent
📊
Strategic Finance M&A
🧬
DeepTech Life Sciences
📈
...

Summary

Lisa Ward is a key figure in venture capital and asset management, currently leading Portfolio Talent and Value Creation at Mercia Ventures. She focuses on a human-centered investment approach, fostering long-term growth and bringing together founders with business leaders to drive transformative ideas. co+3
With a background in science and technology (BSc Hons in Human Bioscience), Lisa has a strong interest in the commercialization of science. She previously worked at Pfizer in academic liaison, supporting STEM educational outreach programs, and later at Grant Thornton in business growth services, specializing in healthcare and life sciences. co+1
Her venture capital career began in 2011, focusing on investing in early-stage companies and participating in over 25 transactions. As an Investment Director at Mercia Fund Managers, she was instrumental in securing funding for innovative firms like Arc Vehicle (electric motorcycles) and SatSense (satellite data for ground movement detection). co+3
Lisa is actively involved in supporting Mercia Ventures' portfolio companies, providing practical guidance, connecting them with industry experts, and helping them navigate market entry, particularly into the US. She emphasizes that CEOs value practical help as much as financial investment. co+1
Lisa is also a member of the Mercia Spirit Committee, a group-wide program translating Mercia's values into initiatives, and has been featured in a Mercia Podcast titled 'Leading with Love' alongside Natasha Wallace. co+1

Work

Education

Hobbies

Enjoys walking, good food, and spending time with family. co+1

Notes

EAEdwin Ablsaid
LWLisa Ward
is known for opening doors and making valuable introductions with a human, non-salesy approach.

Mar 19, 2026